Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Onconova Therapeutics, Inc. (ONTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/15/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/14/2023 4 Shoemaker Mary Teresa (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 4 STOVER JACK E (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 4 Atadja Peter (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 4 Clarke Trafford (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 4 GROOPMAN JEROME (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 4 MARINO JAMES J (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "ONCONOVA THERAPEUTICS, INC. Condensed Consolidated Balance Sheets"
08/04/2023 4 Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,422 shares @ $1.02, valued at $1.5k
Exercised 4,750 restricted stock units @ $0
08/04/2023 4 Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,744 shares @ $1.01, valued at $4.8k
Exercised 12,567 restricted stock units @ $0
07/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/21/2023 8-K Quarterly results
07/12/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/30/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/07/2023 ARS Form ARS - Annual Report to Security Holders:
06/07/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 8-K Quarterly results
Docs: "ONCONOVA THERAPEUTICS, INC. Condensed Consolidated Balance Sheets"
05/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/16/2023 8-K Quarterly results
Docs: "ONCONOVA THERAPEUTICS, INC. Condensed Consolidated Balance Sheets"
03/14/2023 4 Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 79,000 options to buy @ $0.73, valued at $57.7k
Granted 26,000 restricted stock units @ $0
03/14/2023 4 Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 207,000 options to buy @ $0.73, valued at $151.1k
Granted 69,333 restricted stock units @ $0
03/14/2023 4 Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 62,000 options to buy @ $0.73, valued at $45.3k
Granted 20,667 restricted stock units @ $0
02/13/2023 8-K Quarterly results
02/08/2023 4 Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,977 shares @ $1.36, valued at $9.5k
Exercised 21,320 restricted stock units @ $0
02/08/2023 4 Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,242 shares @ $1.36, valued at $1.7k
Exercised 5,833 restricted stock units @ $0
02/08/2023 4 Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,785 shares @ $1.36, valued at $2.4k
Exercised 6,900 restricted stock units @ $0
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy